54-05-7

Chloroquine is a Toll-like receptor inhibitor that inhibits autophagy. Chloroquine has anti-malarial and anti-inflammatory activity and is widely used in the treatment of malaria and rheumatoid arthritis. Chloroquine also has anti-SARS-CoV-2 (COVID-19) activity and anti-HIV-1 activity.

Chloroquine phosphate (Aralen phosphate) is an antimalarial and anti-inflammatory agent widely used for malaria and rheumatoid arthritis. Chloroquine phosphate acts as an inhibitor of autophagy and toll-like receptors, effectively suppressing SARS-CoV-2 (COVID-19) infection (EC50 = 1.13 μM). Chloroquine phosphate can be utilized in research on autophagy, lysosomal function, and tumor diseases.

Chloroquine-D5 diphosphate is the deuterated form of Chloroquine (phosphate). This compound is widely utilized as an antimalarial and anti-inflammatory agent for malaria and rheumatoid arthritis. Additionally, Chloroquine phosphate functions as an inhibitor of autophagy and toll-like receptors (TLRs) and effectively inhibits SARS-CoV-2 (COVID-19) infection.

(+)-Chloroquine, an aminoquinoline drug, inhibits the in vitro terminal glycosylation of angiotensin-converting enzyme 2 (ACE-2) [1].

(-)-Chloroquine is an enantiomer of chloroquine.

Chloroquine-D5 is a deuterated compound of Chloroquine. Chloroquine (T8689) has a CAS number of 54-05-7. Chloroquine (T8689) is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine (T8689) is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine (T8689) is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro with EC50 of 1.13 μM.

Chloroquine-D5 (Standard) is a reference standard of Chloroquine-D5 intended for quantitative analysis, quality control, and related biochemical research applications. Chloroquine-d5 is a deuterated compound of Chloroquine. Chloroquine has a CAS number of 54-05-7. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro with EC50 of 1.13 μM.

Chloroquine is a medication preventing and treating malaria in areas where malaria is known to be sensitive to its effects. It is also sometimes used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. Ch